Jean-Pierre Tarayre

Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid

Anna Kruczynski, Françis C. Colpaert, Jean-Pierre Tarayre et al. · Cancer Chemotherapy and Pharmacology · 1998 · 112 citations

Medicine, Medicinal Chemistry, Pharmacology +8

In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia

Laurent Bardin, Jean-Pierre Tarayre, Wouter Koek et al. · European Journal of Pharmacology · 2001 · 67 citations

Medicine, Anesthesiology, Pharmacology +16

F 11356, a Novel 5-Hydroxytryptamine (5-HT) Derivative with Potent, Selective, and Unique High Intrinsic Activity at 5-HT1B/1D Receptors in Models Relevant to Migraine

Gareth W. John, Petrus J. Pauwels, Michel Perez et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 38 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Pharmacological profile of F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor

Didier Junquéro, Philippe Oms, Elisabeth Carilla-Durand et al. · Biochemical Pharmacology · 2001 · 31 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640

L. A. Bruins Slot, Wouter Koek, Jean-Pierre Tarayre et al. · European Journal of Pharmacology · 2003 · 21 citations

Medicine, Medicinal Chemistry, Pharmacology +15